Raphael Pharmaceutical (RAPH) EBITDA (2020 - 2024)
Raphael Pharmaceutical (RAPH) posted EBITDA of -$394000.0 for Q4 2024, down 23.51% sequentially from -$319000.0 in Q3 2024, and down 394.03% YoY from $134000.0 in Q1 2024.
Raphael Pharmaceutical (RAPH) EBITDA (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical has reported EBITDA for 5 years, with the latest figure at -$394000.0 in Q4 2024.
- Quarterly EBITDA fell 394.03% year-over-year to -$394000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.5 million (down 18.63% YoY) and the FY2025 annual result came in at -$1.2 million, up 17.5% from the prior year.
- EBITDA fell to -$394000.0 in Q4 2024 per RAPH's latest filing, from -$319000.0 in the prior quarter.
- Over five years, EBITDA peaked at $134000.0 in Q4 2023 and troughed at -$1.4 million in Q3 2022.
- A 5-year average of -$467882.4 and a median of -$394000.0 in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2024: EBITDA soared 112.14% in 2023, then sank 394.03% in 2024.
- Over 5 years, EBITDA stood at -$227000.0 in 2020, then tumbled by 152.86% to -$574000.0 in 2021, then slumped by 92.33% to -$1.1 million in 2022, then soared by 112.14% to $134000.0 in 2023, then tumbled by 394.03% to -$394000.0 in 2024.
- According to Business Quant data, EBITDA over the past three periods registered -$394000.0, -$319000.0, and -$249000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -199,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -394,000.00 |
| Sep 30, 2024 | -319,000.00 |
| Jun 30, 2024 | -249,000.00 |
| Mar 31, 2024 | -547,000.00 |
| Dec 31, 2023 | 134,000.00 |
| Sep 30, 2023 | -729,000.00 |
| Jun 30, 2023 | -419,000.00 |
| Mar 31, 2023 | -258,000.00 |
| Dec 31, 2022 | -1.10 Mn |
| Sep 30, 2022 | -1.43 Mn |
| Jun 30, 2022 | -612,000.00 |
| Mar 31, 2022 | -175,000.00 |
| Dec 31, 2021 | -574,000.00 |
| Sep 30, 2021 | -418,000.00 |
| Jun 30, 2021 | -385,000.00 |
| Mar 31, 2021 | -252,000.00 |
| Dec 31, 2020 | -227,000.00 |